Eye gaze and brain computer interface

Summary

This study aims to improve brain-computer interfaces (BCIs) for children with severe disabilities, such as quadriplegic cerebral palsy (qCP). Currently, BCIs assist individuals in controlling things with their minds, but they are not as effective for children with disabilities who may have difficulty focusing their eyes. The study hypothesizes that by only using brain signals when the children are looking straight ahead, the BCIs may work better. To test this idea, we will involve ten children diagnosed with cerebral palsy and ten children with typical development aged 4 to 16. During the study, they will play a fun game while we measure their brain waves, eye movements, and record a video. We will compare the effectiveness of the BCI when focusing only on moments when the children are looking straight ahead versus not doing so. If our hypothesis proves correct, this improvement could significantly benefit these children, enabling them to perform more tasks independently.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 4 to 16

Accepts healthy participants: Yes

Inclusion criteria:

1. Age 4-16 years.
2. Severe motor disability (GMFCS 5, MACS5)
3. Controls with no neurodevelopmental conditions or medications.
4. Written consent/assent.

Exclusion criteria:

1. Severe or unstable epilepsy
2. Behavioral or mental health disorder preventing training or compliance.
3. Children with severe visual impairment will be excluded because the application requires visual interaction with the screen.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Please reach out by email

Principal investigator:

Christopher Kirton

Clinical trial:

No

REB-ID:

REB24-0564